Kira Pharmaceuticals
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
245 Main St Fl 12, Cambridge, Massachuse...Website
www.kirapharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Kira Pharmaceuticals
Founded in 2017 and based out of Cambridge, MA, Kira Pharmaceuticals is a global biotechnology company with a focus on immune-mediated diseases.Explore more
Kira Pharmaceuticals Org Chart
RL
Chief Medical Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kira Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Kira Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Kira Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Kira Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Kira Pharmaceuticals has new funding data
Check out if Kira Pharmaceuticals is spiking on competitors!
Check if Kira Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Kira Pharmaceuticals
Click to see if Kira Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Kira Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Kira Pharmaceuticals
Compare insights from companies similar to Kira Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kira Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kira Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kira Pharmaceuticals.
Kira Pharmaceuticals financials insights
Gather financial insights about Kira Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$18M
2021
Series B
$53.5M
Kira Pharmaceuticals Tech Stack
A closer look at the technologies used by Kira Pharmaceuticals
See more technologies
Most Recent Scoops
Left Company
Executive Move
Kira Pharmaceuticals has announced that Martin Rabe, Senior VP & Head of Global Regulatory Affairs and Quality Assurance, has left the organization to join NeuroTrauma Sciences as Executive VP, Regulatory Affairs & Quality Assurance.
Left Company
Executive Move
New Hire
Executive Move
Left Company
Executive Move
Open Position
Kira Pharmaceuticals News & Media
Kira Pharmaceuticals Presents Positive Results of KP104 Phase 2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Study at European Hematology Association (EHA) Congress 2024 Demonstrating Long-term Safety and Efficacy
CAMBRIDGE, Mass., June 17, 2024 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced positive long-term results from its Phase 2 study of KP104 in complement inhibitor-naïve...Kira Pharmaceuticals to Present Positive Long-term Results of KP104 in Phase 2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Study at the 2024 European Hematology Association (EHA) Hybrid Congress
CAMBRIDGE, Mass., May 16, 2024 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that it will present positive long-term safety and efficacy results from its Phase 2...Kira Pharmaceuticals Presents Positive Results of KP104 Phase 2 Study in Complement-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) at the 2023 ASH Annual Meeting
An Interim analysis of 18 patients, completing 24/25 weeks of treatment in a phase 2 study in complement-naïve PNH patients demonstrates that KP104 is safe, well-tolerated, and has successfully met all primary and secondary endpoints. KP104 effectively managed both intravascular and...Kira to Present at the 41st Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass. and SUZHOU, China, Jan. 5, 2023 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced that Frederick Beddingfield M.D., Ph.D., Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference at 9:00 AM PT on Thursday, January 12, 2023. In advance of the J.P. Morgan presentation, Dr. Beddingfield will participate in a panel discussion title
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kira Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Founded in 2017 and based out of Cambridge, MA, Kira Pharmaceuticals is a global biotechnology company with a focus on immune-mediated diseases.... Read More
